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1. Introduction 
Rapidly Progressive Glomerulonephritis are a group of renal diseases which are still posing 
serious threat to human health and survival. They are all characterised by acute and rapid 
deterioration of renal function. Renal biopsy reveals extracapillary glomerulonephritis, most 
frequently circumferential and diffuse, and immunofluorescence findings continue to 
represent the most important clue toward precise diagnosis. In the last years, with the 
development of new technologies and more targeted animal models, several discoveries 
have been made, that can help in better understanding the pathogenesis and perspectively 
defining new molecular targets for novel therapies, which are still required to improve the 
prognosis of these patients.  
2. Definition 
Introduced for the first time by Ellis in 1942 (Ellis, 1942), the term Rapidly Progressive 
Glomerulonephritis (RPGN) clinically describes a heterogeneous group of 
glomerulonephritis characterised by worsening of kidney function that, if not adequately 
and timely treated, rapidly progresses to end stage renal disease. From the pathological 
point of view, these diseases are classified as extracapillary or crescentic glomerulonephritis, 
generally showing extracapillary proliferation in more than 50% of glomeruli. Besides renal 
biopsy, which is mandatory to make the diagnosis and guide therapeutic decisions, clinical 
symptoms, biochemical exams, and the observation of the urinary sediment are relevant to 
the diagnostic process.  
Observation of the urinary sediment in the acute phase of disease allows to detect in the vast 
majority of cases marked erythrocytic cylindruria, mild to moderate leukocyturia, presence 
of tubular epithelial cells and tubular epithelial cell casts. Fatty casts and leukocyte casts can 
be detected in about one third of cases (Fogazzi, 2009). Progressive disappearance of these 
features follows successful therapeutic intervention, and their reappearance frequently 
precedes disease relapses, making the urinary sediment an important exam not only at 
diagnosis but also during the patient’s follow-up. 
Despite the amelioration of prognosis obtained with introduction of high doses of steroids, 
immunosuppressive agents, and plasma exchange, these diseases are still life-threatening 
and a high percentage of subjects have a poor renal outcome. 
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3. Classification 
Along the years, different schemes for classifying RPGN have been proposed. Among them, 
the classification which is still largely accepted and mostly utilised was proposed by Couser 
(Couser, 1988), and defines disease groups on the basis of immunofluorescent findings. 
Clinical features and haematological exams are as well very important in reaching a precise 
diagnosis (Table 1).  
 
Light microscopy Necrotising extracapillary or pure extracapillary glomerulonephritis 
Immuno-
fluorescence 
Linear IgG staining
None or minimal 
deposits 
Granular deposits 
Hemato-chemical 
exams 
Circulating anti-
GBM antibodies 
ANCA 
Autoantibodies 
 
Complement components 
Clinical features Lung haemorrhage Systemic symptoms Systemic symptoms 
Diagnosis 
Anti-GBM disease
 
Goodpasture’s 
syndrome 
Wegener’s 
granulomatosis 
 
Microscopic 
polyangiitis 
 
Renal limited 
vasculitis 
 
Churg-Strauss 
syndrome 
Post-streptococcal GN 
 
Post-infectious GN 
 
SLE nephritis 
 
IgA GN/HS syndrome 
 
Primary MPGN 
 
Other primary GN 
Table 1. Classification of RPGN according to immunofluorescence findings 
Linear deposition of IgG along the glomerular basement membrane associated to circulating 
anti-GBM antibodies allow the diagnosis of anti-GBM disease. If pulmonary haemorrhage is 
present, the diagnosis becomes of Goodpasture’s Syndrome.  
When immunofluorescence on renal biopsy material demonstrates absence of immune 
deposits or scanty immune deposition in the glomerulus, in association to the presence of 
circulating ANCA antibodies, a diagnosis of pauci-immune ANCA-associated renal 
vasculitis is made. In these cases, necrotising crescentic GN can be associated to clinical 
symptoms of systemic vasculitis. A prevalent involvement of the upper respiratory tract is 
highly suggestive for a diagnosis of Wegener’s Granulomatosis, whereas the presence of 
only general systemic symptoms, such as fever, is highly suggestive of Renal Limited 
Vasculitis. Rarely presenting as RPGN, Churg-Strauss syndrome is diagnosed when asthma 
and increased circulating eosinophils are present.  
Importantly, there is a percentage (10-30%, according to the literature) (Chen, 2009) of renal 
vasculitis which are negative for ANCA antibodies. A part from subjects with circulating 
AECA (anti-endothelial cell antibodies), that according to a recent study may be present in 
about 50% of cases (Cong, 2008), diagnosis is mainly based on clinical and biopsy findings 
and exclusion of other causes. 
Among cases of RPGN with granular immune deposition in glomeruli, the most frequent 
are Post-Streptococcal/post-infectious nephritis and extracapillary GN observed in cases of 
Lupus Nephritis. In these diseases, besides clinical symptoms, diagnosis is made thanks to 
the presence of autoantibodies (ASLO and anti-DNAseB in PSGN, and ANA in SLE).  
www.intechopen.com
 Rapidly Progressive Glomerulonephritis 
 
97 
RPGN can also complicate any primary form of GN, most frequently MPGN and IgA 
nephropathy. A part from the immunofluorescence findings, diagnosis is also guided by 
clinical and biochemical exams, such as the evaluation of complement components for the 
diagnosis of MPGN, and the presence of purpura in cases of Henoch-Schoenlein syndrome.  
It remains to be said, as a word of caution, that it is not infrequent to find a completely 
negative immunofluorescence or immunofluorescence findings particularly difficult to 
interpret in cases with very severe extracapillary proliferation or necrotic lesions, because of 
the consequent compression or destruction of the glomerular tuft.  
4. Morphological findings 
Though the common element characterising this group of diseases is the presence of 
extracapillary proliferation, morphological findings can be very diverse, according to the 
stage of the disease and also to the underlying disease, likely reflecting the different 
pathogenesis of glomerular lesions.  
4.1 Anti-GBM nephritis and Goodpasture’s Syndrome 
By light microscopy, variable degrees of necrotising extracapillary lesions can be observed, 
which range from focal and segmental to global and diffuse (Fig 1).  
 
 
Fig. 1. Anti-GBM nephritis. A large area of necrosis of the glomerular tuft is surrounded by 
a circumferential crescent. Inflammatory cells surround the glomerulus.  
Extracapillary lesions are composed by monocytes, epithelioid macrophages and epithelial 
cells. Glomeruli not involved by these lesions and the parts of the glomerulus not affected 
by necrosis can present normal features, but more commonly they show mild to moderate 
mesangial proliferation, some degree of mesangial matrix expansion, and increased 
leukocyte infiltration. Intraglomerular inflammatory cells are mostly monocyte-
macrophages with variable numbers of T-lymphocytes (Ferrario, 1985; Bolton, 1987). 
In about 50% of cases, multinucleated giant cells can be detected either in the crescent or in 
the periglomerular inflammatory infiltrate, forming the so-called granuloma-like lesions.  
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Generally well corresponding to the degree of glomerular damage, the tubulointerstitium 
shows variable extents of tubular atrophy, oedema, and interstitial inflammation. If the 
biopsy is timely performed, no interstitial fibrosis is observed.  
Vascular lesions are not common, though necrotising arteritis and thrombotic 
microangiopathy have been reported occasionally in the literature (Dean, 1991; Stave, 1984). 
Immunofluorescence is diagnostic, with the linear deposition of IgG along the glomerular 
basement membrane. This aspect can be best appreciated in glomeruli not particularly 
damaged, whereas it is more difficult to be seen when the glomerular capillary is largely 
destroyed by necrosis or compressed by extensive cellular crescents. 
A combination of IgG and C3 can also be found, as well as a linear deposition of IgA or IgM 
(Gris, 1991; Peto, 2011) has been reported. 
Linear IgG staining can be also detected along the Bowman’s capsule, and along the tubular 
basement membranes. Additionally, the fibrinogen antiserum strongly stains the areas of 
necrosis in the tuft and within the crescents. 
4.2 ANCA-associated renal vasculitis 
Irrespective of diagnosis, identical renal microscopy features can be observed in Wegener’s 
granulomatosis, microscopic polyangiitis, and renal limited vasculitis. Necrotising 
glomerulonephritis and extracapillary proliferation are the renal hallmark of these diseases, 
and can be found with variable degrees of association. Necrosis can be present alone in cases 
when renal biopsy is early performed, but more commonly is associated with segmental 
areas of extracapillary proliferation. Particularly compromised glomeruli show instead large 
areas of necrosis of the tuft and circumferential crescents, with frequent rupture of the 
Bowman’s capsule and intense periglomerular leukocyte infiltration, so that the limit of the 
glomerular area is no more distinguishable (Fig 2), and the area has the aspect of a 
granulomatous reaction. 
 
 
Fig. 2. ANCA-associated vasculitis. A large rupture of the Bowman’s capsule can be 
observed.  
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Extracapillary and granuloma-like lesions are mainly made by inflammatory cells, mostly 
acutely activated monocyte-macrophages (Fig. 3, Fig 4) (Rastaldi, 1996; Rastaldi, 2000), 
whose entrance into the glomerulus seems to be facilitated by the de novo expression of the 
adhesion molecule VCAM-1 (Fig 5).  
 
 
Fig. 3. ANCA-associated vasculitis. Glomerular damage and periglomerular granuloma-like 
reaction are mainly composed by monocyte-macrophages, as witnessed by the positivity for 
the marker CD68. 
 
 
Fig. 4. ANCA-associated vasculitis. A vast glomerular granuloma-like reaction is strongly 
positive for the marker of acutely activated monocyte-macrophages 27E10.  
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The acute activation of cells composing the glomerular granuloma-like reaction 
differentiates this type of alteration from other kind of tissue granulomas, where acute 
macrophages have not been found (Bhardwaj, 1992). 
Differently from those observed in other diseases, monocyte-macrophages present in renal 
vasculitis are proliferating cells, as we have shown by staining with antibodies against 
PCNA (Fig 6) and Ki67 (Rastaldi, 2000). 
 
 
Fig. 5. ANCA-associated vasculitis. VCAM-1 de novo expression in damaged areas of the 
glomerulus. 
 
 
Fig. 6. ANCA-associated vasculitis. PCNA labels numerous cells in and around the 
glomerulus. 
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Depending on the timing of renal biopsy, glomeruli can be affected by active lesions or by 
more sclerotic alterations. It is not infrequent to observe both types of lesions in the same 
renal biopsy and even in the same glomerulus (Fig 7). 
 
 
Fig. 7. ANCA-associated vasculitis. The glomerulus shows evident necrotic damage in the 
upper part of the crescent, whereas the lower part is already fibrous. 
Besides periglomerular infiltrates, focal perivascular inflammatory cells are frequently 
detected in the interstitium, and a diffuse interstitial leukocyte infiltration is also present, 
whose degree well corresponds to the extent of glomerular damage. Interstitial cells are 
mainly monocyte-macrophages and T-lymphocytes. 
Prevalence of eosinophils, in association to the clinical symptoms of asthma, and 
increased numbers of circulating eosinophils, stand for a diagnosis of Churg-Strauss 
syndrome. 
By definition, in ANCA-associated renal vasculitis immune deposits are absent or few and 
scattered, hence the term pauci-immune glomerulonephritis. Instead, the fibrinogen 
antiserum strongly stains areas of necrosis of the tuft and fibrin deposits into the 
crescents. 
4.3 Post-infectious glomerulonephritis 
Either post-streptococcal and other post-infectious glomerulonephritis can present with a 
rapidly progressive course, which is indicative of a poor prognosis. 
Several systemic infections, especially occult, such as infective endocarditis, infected atrio-
ventricular shunts, visceral abscesses, and infected vascular prostheses, can be at the origin 
of RPGN. Blood levels of complement can be reduced. 
By light microscopy necrotising lesions, but more frequently extracapillary damage without 
necrosis of the tuft are observed.  
Especially in case of streptococcal infections, the presence of numerous intraglomerular 
granulocytes (so-called glomerular exudative lesions) (Fig 8) is useful for diagnostic 
purposes. 
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In post-streptococcal GN, granular IgG and C3 deposits are the most common finding. IgG, 
C3, and IgM deposits can be observed in other post-infectious GN, at various locations, but 
primarily subendothelial and mesangial.  
 
 
Fig. 8. Post-streptococcal GN. Numerous granulocytes can be observed in the glomerular 
tuft and in the crescent.  
4.4 RPGN complicating primary and secondary glomerular diseases 
Though rarely, any primary or secondary glomerular diseases can be complicated by a 
rapidly progressive course and display necrotising crescentic glomerulonephritis at light 
microscopy. Very recently, a report has shown for the first time the appearance of RPGN 
complicating the course of AL amyloidosis (Crosthwaite, 2010). Cases of association of 
primary or secondary glomerulonephritis and anti-GBM disease or renal vasculitis have 
also been published, as well as cases of association of anti-GBM disease and ANCA-
positive renal vasculitis (Curioni, 2002; O’Connor, 2010). Diagnosis in these patients 
requires skilful and careful analysis of clinical features, renal biopsy findings, and 
hematochemical exams.  
4.4.1 IgA nephropathy and Henoch-Schonlein purpura 
Less than 10% of patients with primary IgA nephropathy or Henoch-Schonlein syndrome 
have been reported with a truly rapidly progressive course (Ferrario, 1997).  
Clinical features of cutaneous purpura or abdominal and joint pain, accompanied by the 
finding of a small vessel leukocytoclastic vasculitis, most frequently detected in skin 
biopsies, help in making a diagnosis of systemic disease.  
Focal segmental or global and diffuse necrotising and extracapillary lesions of the 
glomerulus can be found, or extracapillary lesions can be present without necrosis of the 
glomerular tuft (Fig 9), which always presents variable degrees of mesangial proliferation 
and expansion of the mesangial matrix.  
Immunofluorescence shows prevailing IgA mesangial deposits, possibly in combination 
with IgG and C3 deposition, especially in the systemic disease. 
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Fig. 9. Primary IgA nephropathy. A circumferential crescent surrounds a glomerulus 
affected by mesangial proliferation and mesangial expansion.  
4.4.2 Systemic lupus erythematosus 
Among the histological classes of SLE nephritis (Weening, 2004), RPGN is more frequently 
observed in classes III and IV. In these cases the occurrence of antineutrophil cytoplasmic 
antibodies is not uncommon and is thought to contribute to the development of necrotising 
and crescentic glomerular lesions (Sen, 2003). 
Extensive extracapillary proliferation has been rarely reported (Fig 10), whereas segmental 
necrotising extracapillary alterations are a rather common finding, but not always translate 
in a RPGN clinical phenotype. 
 
 
Fig. 10. Rapidly progressive class IV SLE nephritis. A circumferential crescent surrounds a 
glomerulus affected by intense intracapillary proliferation, mesangial expansion, and 
leukocyte infiltration. 
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Immunofluorescence has the typical findings of lupus nephritis, according to the class of 
disease, with frequent “full house” deposition, and fibrinogen positivity in necrotic areas 
and crescents. 
5. Pathogenesis and experimental models 
In recent years, thanks to the possibilities offered by molecular modelling, genetic studies, 
and the generation of novel animal models better reproducing human disease features, 
important advances have been made in understanding pathogenetic mechanisms 
underlying certain forms of RPGN, especially anti-GBM nephritis and ANCA-associated 
renal vasculitis.  
Instead, it continues to be less clear why a rapidly progressive course can complicate 
virtually any type of primary and secondary glomerulonephritis.  
5.1 Anti-GBM nephritis and Goodpasture’s disease 
The seminal discovery in understanding the pathogenesis of the disease was the 
identification of the antigen that causes production of pathogenic autoantibodies (Saus, 
1988).  
Thereafter, injection of the recombinant antigen, i.e. the noncollagenous domain (NC1) of 
the alpha3chain of collagen type IV, was shown to induce a severe glomerulonephritis in 
Wistar-Kyoto rats (Sado, 1998), hence proving a direct relationship between the self-antigen 
sustaining autoantibody production and the disease.  
More recently, a second class of autoantibodies has been described, which are specific for 
the alpha5NC1 domain, occur in 70% of affected patients, and seem to be associated with a 
worse renal prognosis (Pedchenko, 2010).  
In the normal glomerular basement membrane, the NC1 domain is assembled in 
alpha345NC1 hexamers, whose quaternary organisation has been shown in a three-
dimensional model (Vanacore, 2008) as an ellipsoid-shaped structure composed by two NC1 
trimers joined at the base by hydrophobic and hydrophilic interactions and reinforced by 
sulfilimine bonds. This crosslinked alpha345NC1 hexamer is inert to antibody binding. Anti-
GBM antibodies in fact can bind only to dissociated monomer and dimer subunits that form 
after alteration of the hexamer and expose pathogenic neoepitopes. This explains why 
passive transfer of antibodies to the mouse, where hexamers in the GBM are completely 
crosslinked, does not result in glomerulonephritis (Luo, 2010). 
The major epitopes within the alpha3 and alpha5 subunits have been identified as well, and 
named EA-alpha3, EA-alpha5, and EB-alpha3 (Netzer, 1999; Hellmark, 1999; Pedchenko, 
2010).  
Several questions, primarily regarding the causes of hexamer alteration that induce epitope 
exposure and antibody production, need to be answered. At present, the most accredited 
hypothesis is that environmental factors act in genetically predisposed subjects, leading to 
epitope alteration and antibody formation.  
As for genetic predisposition, positive and negative associations with HLA molecules have 
been found, especially with the MHC class II HLA-DRB1*1501 allele (Yang, 2009), which is 
strongly associated to anti-GBM disease. 
A number of experimental data are in favour of a role played by FcR gene and the 
complement system, though their precise role in humans is still unclear.  
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Instead, several experimental models implicate T-cell mediated immunity in the 
pathogenesis of anti-GBM disease, which is based on the following findings. In rats, anti-
GBM disease can be induced by injecting alpha3(IV)NC1-specific CD4+Tcells (Wu, 2002). 
Anti-CD8 monoclonal antibodies reduce disease severity and antigen-specific CD8+Tcell 
clones have been found in diseased patients (Reynolds, 2002). Invariant natural killer cells 
(iNKT) could have a role as well, because the disease has a worse course in iNKT cell-
deficient mice (Mesnard, 2009). Finally, mice deficient in IL-23, which is important for the 
maintenance of Th17 cells, the CD4+Tcell subset producing IL17, are protected from anti-
GBM disease (Ooi, 2009). 
5.2 ANCA-associated renal vasculitis 
The discovery of ANCAs (Falk, 1988) radically changed not only the diagnosis of small 
vessel vasculitis, but also introduced an important element for the study of the etiology and 
pathogenesis of this group of diseases. Major ANCA autoantigens are two proteins 
contained in azurophil granules of neutrophil granulocytes, MPO and PR3, which are 
mainly expressed during neutrophil development at the myeloblast and promyelocytic 
stage (Cowland, 1999). They are aberrantly expressed in mature neutrophils of ANCA 
patients, whereas are silenced in mature neutrophils of healthy subjects (Yang, 2004).  
In vivo first evidence for a pathogenetic role of ANCA was demonstrated by injection of 
anti-MPO antibodies or anti-MPO lymphocytes, causing a pauci-immune focal necrotising 
extracapillary glomerulonephritis (Xiao, 2002). Subsequent research then showed that in this 
model neutrophil granulocytes are required, because mice depleted of neutrophils do not 
develop the disease, and disease worsening is obtained by priming neutrophils using a pro-
inflammatory stimulus (Xiao, 2005). The model has been also useful in investigating the role 
of the alternative complement pathway, because the disease does not occur in C5 or Factor B 
null mice, but it fully develops in C4-KO animals (Xiao, 2007). 
In an additional model, MPO-KO mice were first immunised with mouse MPO, determining 
production of anti-MPO antibodies. These mice having circulating anti-MPO antibodies 
were then irradiated and subsequently transplanted with MPO-wild type or MPO-KO bone 
marrow cells. A pauci-immune necrotising-crescentic glomerulonephritis developed only in 
mice engrafted with MPO-wild type cells, indicating the requirement for bone marrow 
derived cells in disease development (Schreiber, 2006). 
5.3 Cells involved in crescent formation 
Along the years, composition of glomerular extracapillary proliferation has been, and still 
remains, the object of intense investigation and discussion.  
Though the exact mechanism/s of crescent formation remain elusive, novel animal models 
have recently added important information, that will lead to further clarification of the 
molecular pathways involved and the potential identification of possible novel therapeutic 
targets. 
A word has first to be spent in stating that, morphologically speaking, extracapillary 
proliferation is a heterogeneous phenomenon. It has been shown by several investigators 
that presence or absence of necrosis of the glomerular capillary is relevant to the type of 
crescent. When necrosis is present, the crescent is more inflammatory, and mainly formed 
by monocyte-macrophages. In absence of tuft necrosis, the crescent has more epithelial and 
less inflammatory features. 
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If the presence of inflammatory cells and epithelioid macrophages has never been 
questioned either in animal models and in human disease, opposite data have been obtained 
when attempting to define the epithelial cell composition. 
Until some years ago, both experimental and human studies aiming to study the cells 
contained in the crescents were mostly based on morphological findings and 
immunostaining. The conflicting results produced by these studies were due not only to the 
specific type of experimental model or of human disease under analysis, but especially to a 
dysregulated phenotype with loss of specific markers. In fact, both podocytes and parietal 
epithelial cells are likely to change their original resting phenotype once they start 
proliferating and filling the Bowman’s space.  
The advent of novel experimental models, though not generating unifying and conclusive 
data, is providing more convincing proofs of the participation of either podocytes or parietal 
epithelial cells, based on tagged expression of specific molecules. 
Convincing evidence of podocyte contribution to crescent formation has been shown in a 
podocyte specific mouse model of Vhlh gene knockout (Ding, 2006). These mice showed 
rapidly progressive glomerulonephritis by 4 weeks of age and died by terminal renal failure 
after 3-4 weeks. Histology displayed a crescentic glomerulonephritis, and podocytes 
expressing tagged-ZO1 were found into the crescents. A part from showing podocyte 
participation in crescent formation, the model also identified a novel pathway potentially 
operating in extracapillary glomerulonephritis; deletion of Vhlh in fact resulted in 
stabilisation of hypoxia inducible factor-aplha (HIF1alpha) and consequent upregulation of 
target genes, among them the chemokine receptor CXCR4. Further, podocyte-specific 
expression of CXCR4 was sufficient to induce podocyte proliferation and crescent 
formation, and CXCR4 positivity was observed in glomeruli of human biopsies with 
necrotising extracapillary lesions, suggesting that the VHLH-HIF-CXCR4 pathway may 
have functional relevance also in humans. 
The contribution of parietal epithelial cells to crescent formation has been recently shown in 
a mouse model where a construct containing 3 kb of the human podocalyxin (hPODXL1) 5′ 
flanking region and 0.3 kb of the rabbit Podxl1 5′ untranslated region were used to drive 
expression of rabbit podocalyxin, and transgene expression was detected exclusively within 
PECs but not in podocytes. In this model, injection of nephrotoxic serum caused 
extracapillary glomerulonephritis and cells within crescents could be clearly identified as of 
parietal origin (Smeets, 2009, a). 
As a final consideration, recent work has demonstrated that the Bowman’s capsule contains 
renal progenitors mainly located at the urinary pole of the glomerulus (Ronconi, 2009). If it 
is true that these cells are able to regenerate either tubular cells and podocytes, then their 
participation to crescent formation can be viewed as the pathological consequence of a 
tentative to repair glomerular damage in the course of inflammatory conditions (Smeets, 
2009, b). 
6. Conclusion  
RPGN still constitute a threat for human health and survival. Despite numerous 
improvements in understanding the pathogenesis of these diseases, numerous questions 
still remain unanswered and will need clarification before providing targeted, pathway-
based, novel therapeutics.  
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